Multidrug-resistant tuberculosis in middle ear: A case report

BACKGROUND: Tuberculosis (TB) continues to be a common disease in developing countries, among which middle ear TB is rare. Furthermore, it is relatively difficult to make an early diagnosis and provide follow-up treatment for middle ear TB. So, it is necessary to report this case for reference and f...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Tanze, Liu, Xiuping, Yang, Chengqing, Mei, Chunlin, Ou, Jiali, Du, Ronghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011421/
https://www.ncbi.nlm.nih.gov/pubmed/36926472
http://dx.doi.org/10.1016/j.jctube.2023.100355
Descripción
Sumario:BACKGROUND: Tuberculosis (TB) continues to be a common disease in developing countries, among which middle ear TB is rare. Furthermore, it is relatively difficult to make an early diagnosis and provide follow-up treatment for middle ear TB. So, it is necessary to report this case for reference and further discussion. CASE PRESENTATION: We reported 1 case of multidrug-resistant tuberculosis otitis media. TB otitis media is rare in tuberculosis; multidrug-resistant TB otitis media is even more rare. Our paper analyzes the possible causes, imaging, molecular biology, pathology, and clinical manifestations of multidrug-resistant TB otitis media. CONCLUSION: PCR and DNA molecular biology techniques are highly recommended for the early diagnosis of multidrug-resistant TB otitis media. Early, effective anti-tuberculosis treatment is the guarantee for further recovery for patients with multidrug-resistant TB otitis media.

Ejemplares similares